The estrous cycle modulates early-life adversity effects on mouse avoidance behavior through progesterone signaling

被引:0
|
作者
Blake J. Laham
Sahana S. Murthy
Monica Hanani
Mona Clappier
Sydney Boyer
Betsy Vasquez
Elizabeth Gould
机构
[1] Princeton Neuroscience Institute,
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Early-life adversity (ELA) increases the likelihood of neuropsychiatric diagnoses, which are more prevalent in women than men. Since changes in reproductive hormone levels can also increase the probability of anxiety disorders in women, we examined the effects of ELA on adult female mice across the estrous cycle. We found that during diestrus, when progesterone levels are relatively high, ELA mice exhibit increased avoidance behavior and increased theta oscillation power in the ventral hippocampus (vHIP). We also found that diestrus ELA mice had higher levels of progesterone and lower levels of allopregnanolone, a neurosteroid metabolite of progesterone, in the vHIP compared with control-reared mice. Progesterone receptor antagonism normalized avoidance behavior in ELA mice, while treatment with a negative allosteric modulator of allopregnanolone promoted avoidance behavior in control mice. These results suggest that altered vHIP progesterone and allopregnanolone signaling during diestrus increases avoidance behavior in ELA mice.
引用
收藏
相关论文
共 50 条
  • [41] Transgenerational effects of early-life stress on anxiety behavior in zebrafish (Danio rerio)
    Fontana, Barbara D.
    Alnassar, Nancy
    Parker, Matthew O.
    BEHAVIOURAL PROCESSES, 2023, 208
  • [42] EARLY-LIFE SEIZURES PRODUCE GENDER-SPECIFIC EFFECTS ON SOCIAL BEHAVIOR
    Lugo, Joaquin
    Anderson, A.
    EPILEPSIA, 2008, 49 : 268 - 268
  • [43] Early-life adversity increases morphine tolerance and persistent inflammatory hypersensitivity through upregulation of d opioid receptors in mice
    Singleton, Sam
    Sneddon, Claire
    Bakina, Alice
    Lambert, Jeremy J.
    Hales, Tim G.
    PAIN, 2023, 164 (10) : 2253 - 2264
  • [44] Contributions of inflammatory cytokine signaling to the enduring effects of early-life stress: A serotonin connection?
    Baganz, N.
    Smith, J.
    Harbom, L.
    Castriz, E.
    Robson, M.
    Blakely, R.
    BRAIN BEHAVIOR AND IMMUNITY, 2019, 76 : E2 - E2
  • [45] Contributions of Inflammatory Cytokine Signaling to the Enduring Effects of Early-Life stress: A Serotonin Connection?
    Baganz, Nicole
    Smith, Jarrod
    Harbom, Lise
    Robson, Matthew
    Hewlett, William
    Blakely, Randy
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S326 - S327
  • [46] Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling
    Doenni, V. M.
    Gray, J. M.
    Song, C. M.
    Patel, S.
    Hill, M. N.
    Pittman, Q. J.
    BRAIN BEHAVIOR AND IMMUNITY, 2016, 58 : 237 - 247
  • [47] Effects of early life adversity on male reproductive behavior and the medial preoptic area transcriptome
    Samantha R. Eck
    Jamie L. Palmer
    Charlotte C. Bavley
    Reza Karbalaei
    Evelyn Ordoñes Sanchez
    James Flowers
    Amanda Holley
    Mathieu E. Wimmer
    Debra A. Bangasser
    Neuropsychopharmacology, 2022, 47 : 1231 - 1239
  • [48] Effects of early-life exposure to THIP on phenotype development in a mouse model of Rett syndrome
    Zhong, Weiwei
    Johnson, Christopher Mychal
    Wu, Yang
    Cui, Ningren
    Xing, Hao
    Zhang, Shuang
    Jiang, Chun
    JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2016, 8
  • [49] Effects of early-life exposure to THIP on phenotype development in a mouse model of Rett syndrome
    Weiwei Zhong
    Christopher Mychal Johnson
    Yang Wu
    Ningren Cui
    Hao Xing
    Shuang Zhang
    Chun Jiang
    Journal of Neurodevelopmental Disorders, 2016, 8
  • [50] Effects of early life adversity on male reproductive behavior and the medial preoptic area transcriptome
    Eck, Samantha R.
    Palmer, Jamie L.
    Bavley, Charlotte C.
    Karbalaei, Reza
    Sanchez, Evelyn Ordones
    Flowers, James
    Holley, Amanda
    Wimmer, Mathieu E.
    Bangasser, Debra A.
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (06) : 1231 - 1239